Huperzine A: Is it an Effective Disease-Modifying Drug for Alzheimer’s Disease?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Huperzine A: Is it an Effective Disease-Modifying Drug for Alzheimer’s Disease?
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-08-19
DOI
10.3389/fnagi.2014.00216
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Decreased Accumulation of Subcellular Amyloid-β with Improved Mitochondrial Function Mediates the Neuroprotective Effect of Huperzine A
- (2018) Ling Yang et al. JOURNAL OF ALZHEIMERS DISEASE
- Increased Iron and Free Radical Generation in Preclinical Alzheimer Disease and Mild Cognitive Impairment
- (2017) Mark A. Smith et al. JOURNAL OF ALZHEIMERS DISEASE
- Huperzine A in the Treatment of Alzheimer's Disease and Vascular Dementia: A Meta-Analysis
- (2014) Shu-huai Xing et al. Evidence-based Complementary and Alternative Medicine
- Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease
- (2013) Xiao-Tian Huang et al. NEUROBIOLOGY OF AGING
- Huperzine A for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- (2013) Guoyan Yang et al. PLoS One
- Metallostasis in Alzheimer's disease
- (2012) Scott Ayton et al. FREE RADICAL BIOLOGY AND MEDICINE
- Nerve growth factor: from the early discoveries to the potential clinical use
- (2012) Luigi Aloe et al. Journal of Translational Medicine
- Nerve Growth Factor and Alzheimer's Disease: New Facts for an Old Hypothesis
- (2012) Antonino Cattaneo et al. MOLECULAR NEUROBIOLOGY
- Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
- (2012) Peng Lei et al. NATURE MEDICINE
- Huprine X and Huperzine A Improve Cognition and Regulate Some Neurochemical Processes Related with Alzheimers Disease in Triple Transgenic Mice (3xTg-AD)
- (2012) M. Ratia et al. Neurodegenerative Diseases
- The Role of Phytochemicals in the Treatment and Prevention of Dementia
- (2011) Melanie-Jayne R. Howes et al. DRUGS & AGING
- In Vivo Positron Emission Tomographic Imaging of Glial Responses to Amyloid- and Tau Pathologies in Mouse Models of Alzheimer's Disease and Related Disorders
- (2011) J. Maeda et al. JOURNAL OF NEUROSCIENCE
- An Overview on Natural Cholinesterase Inhibitors - A Multi-Targeted Drug Class - and Their Mass Production
- (2011) I. Erdogan Orhan et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Shift in brain metabolism in late onset Alzheimer’s disease: Implications for biomarkers and therapeutic interventions
- (2011) Jia Yao et al. MOLECULAR ASPECTS OF MEDICINE
- A phase II trial of huperzine A in mild to moderate Alzheimer disease
- (2011) M. S. Rafii et al. NEUROLOGY
- Huperzine A Activates Wnt/β-Catenin Signaling and Enhances the Nonamyloidogenic Pathway in an Alzheimer Transgenic Mouse Model
- (2011) Chun-Yan Wang et al. NEUROPSYCHOPHARMACOLOGY
- Cyclic-AMP response element binding protein and tau are involved in the neuroprotective mechanisms of nerve growth factor during focal cerebral ischemia/reperfusion in rats
- (2010) Zheng-Hong Zhang et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Alzheimer's disease: strategies for disease modification
- (2010) Martin Citron NATURE REVIEWS DRUG DISCOVERY
- Amyloid β-peptide 31-35-induced neuronal apoptosis is mediated by caspase-dependent pathways via cAMP-dependent protein kinase A activation
- (2009) Li Zhao et al. AGING CELL
- A Systematic Review of Single Chinese Herbs for Alzheimer's Disease Treatment
- (2009) Li-Min Fu et al. Evidence-based Complementary and Alternative Medicine
- Huperzine A protects isolated rat brain mitochondria against β-amyloid peptide
- (2009) Xin Gao et al. FREE RADICAL BIOLOGY AND MEDICINE
- Activation of Group III Metabotropic Glutamate Receptor Reduces Intracellular Calcium in β-Amyloid Peptide [31–35]-Treated Cortical Neurons
- (2009) Li Zhao et al. NEUROTOXICITY RESEARCH
- Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease
- (2008) P. Hemachandra Reddy et al. TRENDS IN MOLECULAR MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started